TB LAM AND AG--STRUCTURES CORRELATED WITH BIOLOGY

TB LAM 和 AG——与生物学相关的结构

基本信息

  • 批准号:
    6373436
  • 负责人:
  • 金额:
    $ 18.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-06-01 至 2003-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from the Applicant's Abstract): Important physiological and immunopathogenic features of mycobacteria including slow growth, acid fastness, resistance to drug permeation, and immunological persistence have been attributed to the presence of lipoarabinomannan (LAM) and arabinogalactan (AG) in the cell wall. This competitive renewal of Al 37139 is built on success in the initial funding period of determining structural characteristics of truncated LAM from laboratory induced ethambutol (Emb) resistant M. smegmatis and LAM and AG from clinical isolates of M. tuberculosis resistant to Emb. To take the next step in fully understanding the cell surface of M. tuberculosis and its manifestation in bacterial physiology and pathology, it is proposed to determine the entire structures of LAM and AG, to characterize LAM and AG in a panel of Emb resistant M. tuberculosis isolates, and, in collaboration, to determine and precise structures of LAM needed for CD1 T-cell and macrophage mannose receptor recognition. Although some structural features of LAM and AG have been delineated, key issues, including the structure of the arabinan regions of both polymers, and the site of the arabinan attachments to the hexose backbones of each polymer remain unknown. To obtain the complete primary structure of these two 100 glycosyl residues glycans, novel cell wall degrading enzymes will be used to prepare fragments whose structures will be determined by state-of-the-art nuclear magnetic resonance (NMR) and mass spectrometry (MS) analysis. The enzymes include seven novel arabinanases and galactofuranases secreted by a Cellulomonas species and an endo alpha-1,6 mannosidase from Bacillus circulans. NMR will focus on the analysis of fully 1 3C labeled polysaccharides and polysaccharide fragments by 2-D and 3-D techniques. Mass Spectrometry will feature a novel Q-TOF-tandem electrospray mass spectrometer to obtain sequence information. Techniques based on SDS-PAGE, endo-arabinanase cleavage, 1-D-NMR, and MS will be used to efficiently characterize LAM and AG from our panel of Emb resistant M. tuberculosis. The structural studies will directly aid the immunological studies by providing a wealth of LAM related molecules needed to decipher the structural characteristics necessary for recognition by T-cells and macrophages.
描述(改编自申请人摘要):重要的生理

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DELPHI CHATTERJEE其他文献

DELPHI CHATTERJEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DELPHI CHATTERJEE', 18)}}的其他基金

Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development
HIV/非 HIV 结核病疑似者的尿液/血清 LAM 验证和 POC 测试开发
  • 批准号:
    10179309
  • 财政年份:
    2018
  • 资助金额:
    $ 18.65万
  • 项目类别:
Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development
HIV/非 HIV 结核病疑似者的尿液/血清 LAM 验证和 POC 测试开发
  • 批准号:
    9925722
  • 财政年份:
    2018
  • 资助金额:
    $ 18.65万
  • 项目类别:
Biosynthesis and transbilayer flipping of mycobacterial PIM glycolipids
分枝杆菌 PIM 糖脂的生物合成和跨双层翻转
  • 批准号:
    7511622
  • 财政年份:
    2008
  • 资助金额:
    $ 18.65万
  • 项目类别:
Biosynthesis and transbilayer flipping of mycobacterial PIM glycolipids
分枝杆菌 PIM 糖脂的生物合成和跨双层翻转
  • 批准号:
    7632133
  • 财政年份:
    2008
  • 资助金额:
    $ 18.65万
  • 项目类别:
Anti MDR-TB MICs and Cytotoxicity of New Compounds
新化合物的抗耐多药结核病 MIC 和细胞毒性
  • 批准号:
    6735405
  • 财政年份:
    2003
  • 资助金额:
    $ 18.65万
  • 项目类别:
M AVIUM WALL STRUCTURES FROM AIDS PATIENTS
来自艾滋病患者的 M AVIUM 墙结构
  • 批准号:
    2751059
  • 财政年份:
    1997
  • 资助金额:
    $ 18.65万
  • 项目类别:
M AVIUM WALL STRUCTURES FROM AIDS PATIENTS
来自艾滋病患者的 M AVIUM 墙结构
  • 批准号:
    2545040
  • 财政年份:
    1997
  • 资助金额:
    $ 18.65万
  • 项目类别:
M AVIUM WALL STRUCTURES FROM AIDS PATIENTS
来自艾滋病患者的 M AVIUM 墙结构
  • 批准号:
    6044167
  • 财政年份:
    1997
  • 资助金额:
    $ 18.65万
  • 项目类别:
Structure of LAM in Relation to Biology and Biosynthesis
LAM 结构与生物学和生物合成的关系
  • 批准号:
    6544799
  • 财政年份:
    1996
  • 资助金额:
    $ 18.65万
  • 项目类别:
STRUCTURE OF LAM IN RELATION TO BIOLOGY AND BIOSYNTHESIS
LAM 结构与生物学和生物合成的关系
  • 批准号:
    2672427
  • 财政年份:
    1996
  • 资助金额:
    $ 18.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了